CytoCore, Inc. (CYOE.OB) Picks Sales Veteran to Expand European Penetration
CytoCore Inc., a leading developer of extremely accurate, cost-effective and easily deployable early-warning cytology screening systems, with specific emphasis on gynecological cancers like cervical or endometrial, today announced the retention of Dr. Mauro Scimia to head up the Company’s European marketing and sales division. CEO of CYOE, Robert McCullough Jr., pointed to the outstanding track record of successes in “cervical cytology screening and molecular testing sales combined with his focus on execution and strong management skills” as contributing to his appointment to this position. A 15-year veteran, leading sales, marketing and management concerns with such industry powerhouses as Cytec –…